Ariose Capital Management LTD I Mab Transaction History
Ariose Capital Management LTD
- $154 Million
- Q2 2025
A detailed history of Ariose Capital Management LTD transactions in I Mab stock. As of the latest transaction made, Ariose Capital Management LTD holds 96,455 shares of IMAB stock, worth $200,626. This represents 0.15% of its overall portfolio holdings.
Number of Shares
96,455Holding current value
$200,626% of portfolio
0.15%Shares
1 transactions
Others Institutions Holding IMAB
# of Institutions
38Shares Held
13.9MCall Options Held
20KPut Options Held
13.3K-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$12.4 Million0.15% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.17MShares$8.67 Million3.04% of portfolio
-
Sg Americas Securities, LLC822KShares$1.71 Million0.0% of portfolio
-
Stonepine Capital Management, LLC Bend, OR484KShares$1.01 Million0.39% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny363KShares$755,4560.0% of portfolio
About I-Mab
- Ticker IMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,098,800
- Market Cap $173M
- Description
- I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...